Sign Up For Mailing List Button

Donate to Genetic Alliance

Disease Search Button

NETS - Phase I Clinical Trials (PK, Safety, Dose)

Facebook icon
Google+ icon
Twitter icon
LinkedIn icon
Del.icio.us icon
Digg icon
  • Partnerships
  • Publications
  • Multimedia
  • Worksheets
  • Guides
  • Toolkits
  • Databases
  • Services

What are Phase I clinical trials and why are they important in drug development?

In Phase I clinical trials researchers test a new drug or treatment on a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects: in other words, they study its safety and dose. The pharmacokinetics (PK) of the drug or therapy - are examined as well. The participants in Phase I trials are healthy or unaffected volunteers.

Testimonials: How we did it

Content not yet available for this section.

Relevant Publications

Content not yet available for this section.

 

Twitter icon
Facebook icon
LinkedIn icon
Google+ icon
YouTube icon
RSS icon

4301 Connecticut Ave NW, Suite 404, Washington DC 20008-2369 | Tel: 202.966.5557 | Fax: 202.966.8553 | EIN 52-1571905

Except where otherwise noted, content on this site is licensed under a Creative Commons Attribution 3.0 License.